Calculate your 10-year risk of cardiovascular disease using the ACC/AHA Pooled Cohort Equations. Get statin recommendations and heart age estimate.
The Cardiovascular Disease (CVD) 10-Year Risk Calculator estimates your probability of experiencing a first atherosclerotic cardiovascular event (heart attack or stroke) within the next 10 years using the ACC/AHA Pooled Cohort Equations. These equations, endorsed by the American College of Cardiology and American Heart Association since 2013, form the cornerstone of modern primary prevention guidelines for cardiovascular disease.
Heart disease remains the leading cause of death worldwide, accounting for approximately 17.9 million deaths annually. However, up to 80% of cardiovascular events are preventable through risk factor modification. This calculator evaluates the key modifiable and non-modifiable risk factors: age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, blood pressure treatment status, diabetes, and smoking status.
Based on your calculated risk, the tool provides statin therapy recommendations aligned with ACC/AHA guidelines, an estimated "heart age" (how old your cardiovascular system appears based on risk factors), LDL cholesterol goals, and a detailed breakdown of each risk factor's contribution. This information empowers you to have an informed conversation with your healthcare provider about cardiovascular prevention strategies.
The 10-year ASCVD risk score is the foundation of modern cardiovascular prevention guidelines. It determines whether statin therapy is recommended, guides blood pressure treatment targets, and informs discussions about aspirin therapy. Without knowing your personal risk score, neither you nor your doctor can make fully informed decisions about prevention strategies.
Pooled Cohort Equations (ACC/AHA 2013): Uses sex-specific Cox proportional hazards models Variables: ln(Age), ln(Total Cholesterol), ln(HDL), ln(SBP treated/untreated), Smoking, Diabetes Risk Categories: • Low: <5% • Borderline: 5–7.4% • Intermediate: 7.5–19.9% • High: ≥20% Statin Thresholds: • ≥7.5%: Moderate-intensity statin recommended • ≥20%: High-intensity statin recommended
Result: 10-Year CVD Risk: 14.2% — Intermediate Risk
A 55-year-old male with total cholesterol 240, HDL 40, treated SBP 145, non-diabetic, non-smoker has a 14.2% 10-year ASCVD risk. This falls in the intermediate category, recommending moderate-intensity statin therapy (e.g., atorvastatin 10–20 mg) with an LDL goal <100 mg/dL.
Cardiovascular disease develops over decades through atherosclerosis — the progressive buildup of cholesterol-laden plaques in arterial walls. The major modifiable risk factors (cholesterol, blood pressure, smoking, diabetes, obesity, inactivity) accelerate this process. The PCE quantifies how these factors interact to predict your probability of a first cardiovascular event.
Statins reduce LDL cholesterol by 30–50% and are the most evidence-based intervention for CVD prevention. High-intensity statins (atorvastatin 40–80 mg, rosuvastatin 20–40 mg) reduce LDL by ≥50%. Moderate-intensity statins (atorvastatin 10–20 mg, rosuvastatin 5–10 mg) reduce LDL by 30–49%. Statin therapy has been shown to reduce cardiovascular events by 25–35% relative risk.
The PCE captures the most important risk factors but doesn't include family history, coronary artery calcium score, inflammatory markers (hsCRP), ankle-brachial index, or metabolic syndrome features. These "risk enhancers" can tip clinical decisions for patients in borderline or intermediate risk categories. Coronary artery calcium (CAC) scoring is increasingly used: a CAC of 0 supports deferring statin therapy, while CAC ≥100 supports starting treatment.
It is the estimated probability that you will experience a first atherosclerotic cardiovascular event (non-fatal heart attack, coronary death, or stroke) within the next 10 years, based on the ACC/AHA Pooled Cohort Equations developed from multiple large epidemiological studies. Use this as a practical reminder before finalizing the result.
The PCE are sex- and race-specific Cox regression models developed from 4 large US longitudinal studies (Framingham, ARIC, CARDIA, CHS) comprising over 24,000 participants. They were published in 2013 and are endorsed by ACC/AHA guidelines for primary prevention risk assessment.
ACC/AHA guidelines recommend statin therapy for: (1) confirmed ASCVD (secondary prevention), (2) LDL ≥190 mg/dL, (3) diabetes ages 40–75, and (4) 10-year risk ≥7.5% after risk discussion. For borderline risk (5–7.5%), risk enhancers help guide the decision.
Heart age is a communication tool that expresses your cardiovascular risk as the age of a person with ideal risk factors but the same absolute risk. If your heart age exceeds your actual age, it means your risk factors are aging your cardiovascular system faster than normal.
The original PCE includes race-specific equations for White and African American populations. The equations have been validated in Hispanic/Latino populations with reasonable accuracy. For other populations, the equations may over- or under-estimate risk.
The most effective interventions: (1) quit smoking (reduces risk ~50% in 1 year), (2) exercise 150+ min/week moderate activity (reduces risk ~35%), (3) healthy diet (DASH or Mediterranean, reduces risk ~25%), (4) maintain healthy weight, (5) control blood pressure <130/80, (6) statin therapy when indicated. Keep this note short and outcome-focused for reuse.